Skip to content

All best practices

CS-078mixed

Siemens AG

'Vision 2020' and 'Vision 2020+' portfolio and structure programme, including the Healthineers listing and Siemens Energy spin-off (2014–2020)

Region
Western Europe, Global
Country
Germany
Industry
Diversified Conglomerate (Other (cross-industry))
Functions
Strategy, Corporate Development & Transformation Office, Finance & FP&A, HR & Workforce, Operations & Service Delivery
Topics
Margins are eroding despite revenue; Investment capital is not generating returns; M&A integration or corporate complexity is destroying value; Bureaucracy and slow decisions prevent agility
Starting situation
Group of business units
Period
2014–2020
Last verified
1 November 2026

Executive summary

In May 2014 Siemens' new chief executive, Joe Kaeser, announced 'Vision 2020': a simpler structure, a separately managed healthcare business, a portfolio focused on electrification, automation and digitalisation; in December 2014 it published margin ranges for every business [C01, C02]. Over six years Siemens removed its sector layer, cut divisions from 16 to nine, listed Siemens Healthineers, merged its wind business with Gamesa and spun off Siemens Energy [C05, C08, C12, C16].

Siemens reported €1bn of simplification savings achieved ahead of plan by fiscal 2016, record free cash flow of €6.4bn in fiscal 2020 and an Industrial Businesses margin of 14.3% [C07, C18]. Revenue fell from about €76bn in 2013 to €57.1bn in fiscal 2020 as businesses were separated [C19].

The three numbers that matter: Power and Gas's margin of 3.0% in fiscal 2018 against its 11–15% range [C02, C14]; the Healthineers listing at €28 a share, raising about €4.2bn against about €9bn analysts had expected [C12]; and Siemens Energy's €16bn market value at listing, below analysts' €17–24bn [C17].

Outcome: classed mixed. The structural and separation aims were reported met. But Power and Gas never reached its margin range in the sources read before it was separated, and the planned combination of Mobility with Alstom was prohibited by the European Commission [C14, C15].

The one lesson, as the KB reads it: publishing margin ranges by business makes underperformance visible early, and turns the portfolio question into one the board can answer with numbers.

Outcome: mixed

Documented shortfalls or reversals sit alongside documented gains. For example: an initial failure later recovered, or a strategic goal met while a major adverse event in the same programme was recorded.

Basis of the outcome

Documented gains, company-reported: the sector level removed and divisions cut from 16 to nine (S04); €1bn of simplification savings achieved ahead of plan (S06); Healthineers listed and Siemens Energy spun off (S11, S15, S16); an Industrial Businesses margin of 14.3% and free cash flow of €6.4bn in fiscal 2020 (S17). Documented shortfalls of the programme itself: Power and Gas reported a 3.0% margin in fiscal 2018 against its 11–15% range (S02, S13), and further job cuts were needed (S08); the Mobility–Alstom combination named in Vision 2020+ (S12) was prohibited by the European Commission (S14), leaving Mobility inside Siemens at period end. The Healthineers and Siemens Energy valuations below analysts' expectations (S11, S16) are recorded but not counted, since no programme target for them was published. Mixed rests on two independent grounds. (1) The Alstom prohibition is the failure of a named programme element: the Q3 fiscal 2018 shareholder letter (S12) placed Mobility among the Strategic Companies until 'the completion of its planned combination with Alstom', and after the Commission's prohibition (S14) that element was not delivered and Mobility remained inside Siemens at period end. It was a regulator's decision, not a reversal by Siemens, but under the outcome criteria an unmet element of the programme that remains at period end counts. (2) The Siemens Energy spin-off did not resolve the Power and Gas shortfall; it moved the business out of Siemens' reported perimeter. No source read reports Power and Gas, or Siemens Energy, reaching the 11–15% range, Siemens kept 35.1% of the separated company (S15), and the listing valued it below analysts' range (S16). Either ground alone would support mixed.

Key figures

PhaseFigureValueWhenVerification
BeforeFiscal 2014 revenue / net income / employees€71.9bn / €5.5bn / about 357,000FY2014company_reported
BeforeDivisions16 → 9 plus Healthcare; sector level removed1 Oct 2014company_reported
BeforeVision 2020 targetsROCE 15–20%; margin ranges by business; €1bn savingsDec 2014company_reported
DuringDresser-Rand acquisitionUS$7.6bn2014–2015company_reported
DuringJob cuts announcedabout 7,800 (2015); about 6,900 (2017)2015–2017company_reported
DuringSimplification savings€1bn achieved ahead of planFY2016company_reported
DuringIndustrial Business profit / margin€8.7bn / 10.8%FY2016company_reported
DuringHealthineers IPO15% at €28; about €4.2bn raised; about €28bn valueMar 2018press_reported
DuringPower and Gas margin3.0% (10.2% FY2017) vs 11–15% rangeFY2018company_reported
DuringSiemens Mobility–Alstom mergerprohibited6 Feb 2019press_reported
AfterSiemens Energy spin-off55% to shareholders; 35.1% retained; €16bn value at listing28 Sep 2020company_reported
AfterIndustrial Businesses margin14.3% (adjusted EBITA)FY2020company_reported
AfterFree cash flow€6.4bn, highest in ten yearsFY2020company_reported
AfterRevenue / employees€57.1bn / about 293,000FY2020company_reported
company_reported
A company statement, press release or investor presentation that no one has independently checked.
press_reported
A journalist's own reporting.

Sources

  1. S01 Siemens unveils overhaul · not stated, Business Report / IOL (Reuters), 2014-05-07 · accessed 2026-11-01
  2. S02 Capital Market Day: Vision 2020 (Joe Kaeser) · Joe Kaeser, Siemens AG, 2014-12-09 · accessed 2026-11-01
  3. S03 Siemens defends $7.6bn Dresser-Rand deal · not stated, Financial Times (syndicated by euro2day.gr), 2015-01-27 · accessed 2026-11-01
  4. S04 Siemens drives structural optimization and growth orientation · Siemens AG, Siemens AG, 2015-02-06 · accessed 2026-11-01
  5. S05 Earnings release Q4 FY 2016: twice-raised guidance exceeded · Siemens AG, Siemens AG, 2016-11-10 · accessed 2026-11-01
  6. S06 Q4 FY 2016 analyst presentation · Siemens AG, Siemens AG, 2016-11-10 · accessed 2026-11-01
  7. S07 Siemens, Gamesa wrap up merger process, register new company · not stated, Offshore WIND, 2017-04-03 · accessed 2026-11-01
  8. S08 Siemens tackles structural market changes and strengthens global competitiveness · Siemens AG, Siemens AG, 2017-11-16 · accessed 2026-11-01
  9. S09 Siemens to cut 6,900 jobs worldwide, half of them in Germany · not stated, CNBC, 2017-11-16 · accessed 2026-11-01
  10. S10 Siemens plans IPO of Siemens Healthineers AG in the first half of calendar year 2018 · Siemens Healthineers, Siemens Healthineers, 2018-02-20 · accessed 2026-11-01
  11. S11 Siemens health unit shares surge in Frankfurt debut · not stated, The Local Germany (AFP), 2018-03-17 · accessed 2026-11-01
  12. S12 Shareholder letter Q3 FY 2018 · Siemens AG, Siemens AG, 2018-08 (not printed; share-price window ends 2 Aug 2018) · accessed 2026-11-01
  13. S13 Earnings release Q4 FY 2018 · Siemens AG, Siemens AG, 2018-11-08 · accessed 2026-11-01
  14. S14 Siemens-Alstom merger blocked by European Commission · not stated, Railway Gazette International, 2019-02-06 · accessed 2026-11-01
  15. S15 One Siemens Energy share for every two Siemens shares · Siemens Energy, Siemens Energy, 2020-05-26 · accessed 2026-11-01
  16. S16 Siemens Energy spinoff lags in debut · Ed Frankl (AFP), TechXplore (AFP), 2020-09-28 · accessed 2026-11-01
  17. S17 Fiscal 2020: reliable performance in remarkable times · Siemens AG, Siemens AG, 2020-11-12 · accessed 2026-11-01
  18. S18 After years of restructuring, Siemens has a new CEO · not stated, TechXplore (AFP), 2021-02-03 · accessed 2026-11-01

Researched and fact-checked knowledgebase · Knowledgebase built 5 November 2026 · Last verified 1 November 2026

Practices, their evidence grades and case summaries are public. Full case studies are available in AXIOM to subscribers and AXIOM Discover participants.